Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO).

NCT ID: NCT06952127

Last Updated: 2025-04-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

22 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-07

Study Completion Date

2024-03-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study pilot randomized controlled study is to evaluate the feasibility of the study procedures and to compare the preliminary efficacy of a rehabilitation program given in a "remote" (telerehabilitation) or "face-to-face" model for adult patients who had confirmed SARS-CoV-2 infection and still have symptoms after eight weeks of infection. The main question it aims to answer is:

* Are the study procedures feasible?
* Will the two groups have similar results for the preliminary efficacy outcomes?

Researchers will compare group telerehabilitation to a face-to-face group to see if it's comparable.

Participants will:

* Take part in a 60-minute training session, 3 times a week in person or remotely
* Visit the clinic before starting the training program and after 8 weeks of training
* Keep a diary of their symptoms, if any

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Long COVID-19 Syndrome Long COVID Long COVID Syndrome

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

telerehabilitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Telerehabilitation group

Rehabilitation program including cardiovascular, muscular and balance training and, if necessary, respiratory physiotherapy using the Teams platform supervised by a certified kinesiologist. The rehabilitation will be conducted 3 times a week for 8 weeks in group of 5 or 6 persons.

Group Type EXPERIMENTAL

Rehabilitation program

Intervention Type OTHER

* 5-minute warm-up including easy global exercises
* 5 resistance training exercises targeting upper and lower muscle groups
* 30 secondes break between sets
* Cooldown with breathing and stretching exercises

Face-to-face group

Rehabilitation program including cardiovascular, muscular and balance training and, if necessary, respiratory physiotherapy at the university kinesiology clinic supervised by a certified kinesiologist. The rehabilitation will be conducted 3 times a week for 8 weeks in group of 5 or 6 persons.

Group Type ACTIVE_COMPARATOR

Rehabilitation program

Intervention Type OTHER

* 5-minute warm-up including easy global exercises
* 5 resistance training exercises targeting upper and lower muscle groups
* 30 secondes break between sets
* Cooldown with breathing and stretching exercises

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rehabilitation program

* 5-minute warm-up including easy global exercises
* 5 resistance training exercises targeting upper and lower muscle groups
* 30 secondes break between sets
* Cooldown with breathing and stretching exercises

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients (≥18 years)
* confirmed SARS-CoV-2 infection defined by positive polymerase chain reaction (PCR) testing and/or antigen test results
* referred to the pneumology clinic for a modified British Medical Research Council (mMRC) dyspnea score of 2-3 after a minimum of eight weeks of infection
* VO₂max of less than 80% of the predicted value
* receiving a medical prescription for rehabilitation following initial assessment by a pulmonologist
* being able to walk independently
* providing informed consent
* having a good internet connection (i.e., a minimum download speed of 4 Mbps and an upload speed of 4 Mbps)
* being in possession of a computer or tablet equipped with a camera enabling videoconferencing.

Exclusion Criteria

* requiring in-hospital rehabilitation at discharge
* evidence of medical instability (i.e., moderate or severe cardiac disease, ischemic or severe hemorrhagic stroke, or neurodegenerative disease, unstable fracture)
* history of severe cognitive or mental impairment
* already enrolled in another rehabilitation program
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marie-Claude Lehoux

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre hospitalier affilié universitaire régional

Trois-Rivières, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

889

Identifier Type: REGISTRY

Identifier Source: secondary_id

2023-667

Identifier Type: -

Identifier Source: org_study_id